Lowering blood sugar levels halves the likelihood of serious heart problems in people with prediabetes.

Europe calls for decisive action to transform how Europe monitors noncommunicable diseases (NCDs). Developed jointly by Joint Action on Cardiovascular Diseases and Diabetes (JACARDI), Joint Action Prevent Non-Communicable Diseases (JA PreventNCD), and the WHO Regional Office for Europe (WHO/Europe), a new paper sets out five priority actions to strengthen health monitoring systems across the region, an essential step to curb the rising burden of NCDs and mental health and ensure more effective, equitable health care.

Integrating methadone treatment into primary care settings improves adherence to guideline-concordant health care for opioid use disorder (OUD), according to a study published online Dec. 9 in the Annals of Internal Medicine.

SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, has unveiled new data on a novel approach to chronic pain management and joint tissue preservation. The data highlight SN101, a first-in-class induced pluripotent stem cell (iPSC)-derived therapy.

The U.S. Food and Drug Administration has approved Omisirge (omidubicel-onlv) as the first hematopoietic stem cell transplant therapy to treat patients with severe aplastic anemia (SAA).